Bioseed

Hyderabad, India Founded: 1992 • Age: 34 yrs Listed
Developer of improved agricultural genetics
Request Access
Report Incorrect Data
Page last updated

About Bioseed

Bioseed is a publicly listed company based in Hyderabad (India) founded in 1992. Developer of improved agricultural genetics. The company has 5,854 employees. Its Indian entity Dcm Shriram Limited reported revenue of ₹14,249 Cr.

Company details

Bioseed was founded in 1992 in Hyderabad, India, focusing on the agricultural genetics sector. Improved seed varieties for various crops are developed through research, production, and field trials. High-quality seeds are delivered to farmers, with support provided to optimize their use. Agricultural productivity is enhanced via these genetic advancements, with operations centered in India.

  • Headquarters Hyderabad, India
  • Employees 5,854
  • Stage Public
  • Website bioseed.com
  • Legal Name Dcm Shriram Limited
  • Date of Incorporation 06 Feb, 1989
  • Jurisdiction New Delhi, Delhi, India
Key Metrics
  • Market Cap
    ₹14,252 Cr

    DCMSHRIRAM · NSE

  • Share Price
    ₹912.50

    -0.16% today

  • Revenue
    ₹14,053 Cr

    FY 2025-26 · +13.0% YoY

  • EBITDA
    ₹1,474 Cr

    Margin 10.5%

  • Net Profit
    ₹846 Cr

    FY 2025-26 · +49.1% YoY

  • P/E (TTM)
    11.0x

    P/B 2.0x

  • ROE
    11.6%

    ROCE 11.2%

  • Debt / Equity
    0.37

    Interest cover 18.1x

  • Employee Count
    5,854

Board of directors of Dcm Shriram Limited (Bioseed)

Dcm Shriram Limited is the primary company behind Bioseed. The board of Dcm Shriram Limited currently have 14 directors; the longest-serving is Ajay Shridhar Shriram, appointed in 1989. 29 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Ajay Shridhar Shriram
DIN 00027137
Managing Director24 Jul 198937 yrs 3 moDcm Shriram Limited
Vikram Shridhar Shriram
DIN 00027187
Managing Director22 May 199036 yrs 5 moDcm Shriram Limited
Pradeep Dinodia
DIN 00027995
Director18 Jul 199432 yrs 3 moDcm Shriram Limited
Ajit Shridhar Shriram
DIN 00027918
Managing Director02 May 201115 yrs 5 moDcm Shriram Limited
Pravesh Sharma
DIN 02252345
Director09 Aug 201610 yrs 2 moDcm Shriram Limited
Vikramajit Sen
DIN 00866743
Director09 Aug 201610 yrs 2 moDcm Shriram Limited
Krishan Kumar Sharma
DIN 07951296
Whole-time director20 Nov 20178 yrs 11 moDcm Shriram Limited
Aditya Ajay Shriram
DIN 10157483
Managing Director02 Jul 20233 yrs 3 moDcm Shriram Limited
Rabi Narayan Mishra
DIN 10377015
Nominee Director01 Nov 20232 yrs 11 moDcm Shriram Limited
Pranam Wahi
DIN 00031914
Director16 Jul 20242 yrs 3 moDcm Shriram Limited
Seema Bahuguna
DIN 09527493
Director16 Jul 20242 yrs 3 moDcm Shriram Limited
Simrit Kaur
DIN 10628625
Director16 Jul 20242 yrs 3 moDcm Shriram Limited
Vipin Sondhi
DIN 00327400
Director16 Jul 20242 yrs 3 moDcm Shriram Limited
Tejpreet Singh Chopra
DIN 00317683
Director18 Jan 20251 yr 9 moDcm Shriram Limited

IPO & Listings of Bioseed

Bioseed is a publicly listed company on the NSE with ticker symbol DCMSHRIRAM in India, operating in the Diversified sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • Listed onNSE: DCMSHRIRAM
  • Listed entityDcm Shriram Limited
  • Exchange sectorDiversified

Financials of Bioseed

Exchange-reported figures of Dcm Shriram Limited, the listed company behind Bioseed (NSE: DCMSHRIRAM).

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹14,053 Cr
+13.0% YoY
EBITDA
₹1,474 Cr
+10.8% YoY
Profit After Tax
₹846 Cr
+49.1% YoY
Net Worth
₹7,712 Cr
+10.1% YoY
Total Assets
₹11,034 Cr
+11.8% YoY
Total Debt
₹2,923 Cr
+15.6% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue14,05312,44111,21411,7979,8798,6108,055
Revenue growth+13.0%+10.9%-4.9%+19.4%+14.8%+6.9%-
EBITDA1,4741,3309911,6061,7961,1521,178
EBITDA margin+10.5%+10.7%+8.8%+13.6%+18.2%+13.4%+14.6%
Profit before tax9929096991,4131,565889897
Net profit8465684208851,048666716
Net profit margin+6.0%+4.6%+3.7%+7.5%+10.6%+7.7%+8.9%
EPS (₹)54.4538.5528.5258.1168.0942.9545.72
Balance sheet
Total assets11,0349,8688,9808,1907,3406,4246,565
Net worth7,7127,0046,5226,1945,5024,6484,050
Total debt2,9232,5292,1521,7071,5771,5212,150
Cash & bank8549866729741,6071,334560
Net working capital3,0132,8932,4162,6283,3692,8022,842
Cash flow
Cash from operations1,2341,1277941,2961,2241,887496
Cash from investing(1,241)(850)(1,070)(1,543)(888)(642)(518)
Cash from financing(307)(0.53)169(235)(275)(918)183
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue3,9773,5643,1933,8113,2723,2622,8773,367
Revenue growth (YoY)+21.6%+9.3%+11.0%+13.2%+10.6%+13.4%--
Other income27.4710778.1728.7298.8322.2221.2841.09
EBITDA291337353477309304405496
EBITDA margin+7.4%+9.5%+11.1%+12.6%+9.5%+9.3%+14.3%+14.8%
Depreciation131128138134119112114109
Interest35.4641.0939.6648.8943.0744.0442.5542.77
Profit before tax152274254322246170270386
Tax47.80(418)(117)11087.1456.3490.88123
Net profit105692371213159114179262
EPS (₹)6.7244.4223.7113.5910.147.2711.4716.81
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue13,57012,13010,94011,5169,6918,4967,944
Revenue growth+11.9%+10.9%-5.0%+18.8%+14.1%+7.0%-
EBITDA1,4181,2689571,5881,7651,1381,197
EBITDA margin+10.5%+10.5%+8.7%+13.8%+18.2%+13.4%+15.1%
Profit before tax9628586711,4541,540876923
Net profit8315313999361,027651737
Net profit margin+6.1%+4.4%+3.7%+8.1%+10.6%+7.7%+9.3%
EPS (₹)53.4336.1427.1961.3466.9142.2647.44
Balance sheet
Total assets10,9629,8679,0228,2597,3536,4666,624
Net worth7,7067,0216,5776,2695,5264,6934,105
Total debt2,8892,5182,1451,7071,5711,5202,148
Cash & bank7088976089151,5501,304541
Net working capital2,7272,7112,2812,5053,4062,7872,770
Cash flow
Cash from operations1,2131,0967821,3061,2011,869502
Cash from investing(1,585)(827)(1,055)(1,559)(886)(639)(525)
Cash from financing14.471.90164(229)(280)(914)184
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue3,8903,4393,0323,6663,2173,1562,8123,273
Revenue growth (YoY)+20.9%+9.0%+7.8%+12.0%+11.8%+12.1%--
Other income43.6713579.3030.2399.1621.5420.8440.91
Total expenses3,5813,1212,6913,2112,9062,8772,4172,797
EBITDA309318341455311279395476
EBITDA margin+8.0%+9.3%+11.3%+12.5%+9.7%+8.9%+14.2%+14.6%
Depreciation125122131127115109112106
Interest34.6440.1738.7148.4641.9943.7641.9542.67
Profit before tax194291250310254148263368
Tax49.37(421)(121)10885.3250.8287.99119

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 28 Oct 2026
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue3,9773,5643,1933,8113,2723,2622,8773,367
Revenue growth (YoY)+21.6%+9.3%+11.0%+13.2%+10.6%+13.4%--
Other income27.4710778.1728.7298.8322.2221.2841.09
EBITDA291337353477309304405496
EBITDA margin+7.4%+9.5%+11.1%+12.6%+9.5%+9.3%+14.3%+14.8%
Depreciation131128138134119112114109
Interest35.4641.0939.6648.8943.0744.0442.5542.77
Profit before tax152274254322246170270386
Tax47.80(418)(117)11087.1456.3490.88123
Net profit105692371213159114179262
EPS (₹)6.7244.4223.7113.5910.147.2711.4716.81
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue14,05312,44111,21411,7979,8798,6108,055
Revenue growth+13.0%+10.9%-4.9%+19.4%+14.8%+6.9%-
Other income19614298.5412091.9092.07102
Total expenses12,57911,11010,22410,1918,0837,4576,877
Employee cost1,2601,070984891783733736
EBITDA1,4741,3309911,6061,7961,1521,178
EBITDA margin+10.5%+10.7%+8.8%+13.6%+18.2%+13.4%+14.6%
Depreciation502410303260238233219
Interest17615387.5552.8185.37122164
Profit before tax9929096991,4131,565889897
Tax136305252502499217178
Net profit8465684208851,048666716
Net profit margin+6.0%+4.6%+3.7%+7.5%+10.6%+7.7%+8.9%
EPS (₹)54.4538.5528.5258.1168.0942.9545.72
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital31.3531.3531.3531.3531.3531.3531.35
Reserves & surplus7,6846,9766,4956,1685,4764,6234,026
Shareholders' funds (net worth)7,7127,0046,5226,1945,5024,6484,050
Minority interest20.860.000.000.000.000.006.14
Secured loans2,2592,1081,9571,5951,4371,3401,808
Unsecured loans664420195112141181342
Total debt2,9232,5292,1521,7071,5771,5212,150
Total liabilities11,0349,8688,9808,1907,3406,4246,565
Assets
Gross block9,7948,3005,6805,3004,3954,1604,101
Net block7,5186,5174,2224,1053,4083,3603,499
Capital work in progress5718342,6151,63049410959.12
Investments13655.8353.7212.183.0130.2528.78
Inventories3,1082,7992,6772,3762,3061,8042,177
Sundry debtors1,0819196468699075141,079
Cash & bank balances8549866729741,6071,334560
Loans & advances458388465466358513595
Total current assets5,5015,0934,4604,6865,1774,1654,412
Total current liabilities2,4882,2002,0442,0571,8091,3631,570
Net working capital3,0132,8932,4162,6283,3692,8022,842
Total assets11,0349,8688,9808,1907,3406,4246,565
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash620343450932870543382
Net cash from operating activities1,2341,1277941,2961,2241,887496
Net cash from investing activities(1,241)(850)(1,070)(1,543)(888)(642)(518)
Net cash from financing activities(307)(0.53)169(235)(275)(918)183
Net change in cash(314)277(107)(482)61.56327161
Closing cash8549866729741,6071,334560
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+13.0%+10.9%-4.9%+19.4%+14.8%+6.9%-
EBITDA growth+10.8%+34.3%-38.3%-10.6%+55.9%-2.2%-
PBT growth+9.1%+30.2%-50.6%-9.7%+76.0%-0.9%-24.0%
Net income growth+49.1%+35.3%-52.6%-15.5%+57.4%-7.0%-
Revenue CAGR (3Y)+6.0%+8.0%+9.2%+13.6%+7.2%+7.7%+11.6%
EBITDA CAGR (3Y)-2.8%-9.5%-4.9%+10.9%+9.5%+3.6%+15.2%
Profitability & leverage
Net income margin+6.1%+4.9%+4.0%+7.7%+10.8%+7.8%+8.9%
Return on capital employed+11.2%+11.3%+9.2%+18.9%+24.0%+15.6%+17.8%
Return on net worth+11.6%+8.9%+7.0%+15.6%+21.0%+15.5%+19.0%
Debt / equity0.370.350.300.280.310.420.50
Long-term debt / equity0.220.220.210.190.200.230.25
Interest cover18.0816.6112.733.925.4813.2717.09
Efficiency & per share
Fixed asset turnover1.631.872.142.542.362.082.24
Inventory turnover5.004.794.645.274.924.323.93
Debtors turnover14.7816.7515.4813.8914.2210.817.61
EPS (₹)54.4538.5528.5258.1168.0942.9545.72
Dividend per share (₹)11.209.006.6014.0014.709.308.20
Book value per share (₹)492.20447.05416.38395.48351.34296.91258.82
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue3,8903,4393,0323,6663,2173,1562,8123,273
Revenue growth (YoY)+20.9%+9.0%+7.8%+12.0%+11.8%+12.1%--
Other income43.6713579.3030.2399.1621.5420.8440.91
Total expenses3,5813,1212,6913,2112,9062,8772,4172,797
EBITDA309318341455311279395476
EBITDA margin+8.0%+9.3%+11.3%+12.5%+9.7%+8.9%+14.2%+14.6%
Depreciation125122131127115109112106
Interest34.6440.1738.7148.4641.9943.7641.9542.67
Profit before tax194291250310254148263368
Tax49.37(421)(121)10885.3250.8287.99119
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue13,57012,13010,94011,5169,6918,4967,944
Revenue growth+11.9%+10.9%-5.0%+18.8%+14.1%+7.0%-
Other income19914298.8717593.8989.67101
Total expenses12,15310,8629,9839,9287,9267,3586,746
Employee cost1,2061,044964874772716700
EBITDA1,4181,2689571,5881,7651,1381,197
EBITDA margin+10.5%+10.5%+8.7%+13.8%+18.2%+13.4%+15.1%
Depreciation482400297256235230215
Interest17315287.4652.6585.07122160
Profit before tax9628586711,4541,540876923
Tax124292245493491213180
Net profit8315313999361,027651737
Net profit margin+6.1%+4.4%+3.7%+8.1%+10.6%+7.7%+9.3%
EPS (₹)53.4336.1427.1961.3466.9142.2647.44
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital31.3531.3531.3531.3531.3531.3531.35
Reserves & surplus7,6786,9936,5506,2435,5004,6674,081
Shareholders' funds (net worth)7,7067,0216,5776,2695,5264,6934,105
Secured loans2,2432,1012,0401,5951,4311,3401,808
Unsecured loans647417105112140180340
Total debt2,8892,5182,1451,7071,5711,5202,148
Total liabilities10,9629,8679,0228,2597,3536,4666,624
Assets
Gross block9,0818,0645,4645,1654,2664,0523,978
Net block6,9496,3064,0223,9823,2863,2513,383
Capital work in progress5678322,6121,61449510959.57
Investments94944842334798.5974.7974.79
Inventories2,9372,7342,6152,3292,2471,7622,144
Sundry debtors9948615927908545021,069
Cash & bank balances7088976089151,5501,304541
Loans & advances468372454452486522534
Total current assets5,1084,8654,2704,4875,1364,0894,289
Total current liabilities2,3802,1541,9881,9821,7311,3021,519
Net working capital2,7272,7112,2812,5053,4062,7872,770
Total assets10,9629,8679,0228,2597,3536,4666,624
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash554284394875840524364
Net cash from operating activities1,2131,0967821,3061,2011,869502
Net cash from investing activities(1,585)(827)(1,055)(1,559)(886)(639)(525)
Net cash from financing activities14.471.90164(229)(280)(914)184
Net change in cash(357)270(110)(481)34.42316160
Closing cash7088976089151,5501,304541
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+11.9%+10.9%-5.0%+18.8%+14.1%+7.0%-
EBITDA growth+11.8%+32.5%-39.8%-10.1%+55.2%-5.0%-
PBT growth+12.0%+27.9%-53.9%-5.5%+75.8%-5.2%-21.8%
Net income growth+56.7%+32.8%-57.3%-8.9%+57.8%-11.7%-
Revenue CAGR (3Y)+5.6%+7.8%+8.8%+13.2%+7.0%+7.7%+11.5%
EBITDA CAGR (3Y)-3.7%-10.5%-5.6%+9.9%+8.9%+3.0%+18.4%
Profitability & leverage
Net income margin+6.2%+4.7%+3.9%+8.4%+10.8%+7.8%+9.4%
Return on capital employed+10.9%+10.7%+8.8%+19.3%+23.5%+15.2%+18.0%
Return on net worth+11.4%+8.3%+6.6%+16.3%+20.5%+15.1%+19.4%
Debt / equity0.370.340.300.280.300.420.49
Long-term debt / equity0.220.210.210.190.200.230.25
Interest cover18.4817.4913.263.955.5613.4116.28
Efficiency & per share
Fixed asset turnover1.671.892.152.552.382.122.28
Inventory turnover5.044.784.635.274.954.353.94
Debtors turnover15.4217.6116.5714.6614.6310.827.59
EPS (₹)53.4336.1427.1961.3466.9142.2647.44
Dividend per share (₹)11.209.006.6014.0014.709.308.20
Book value per share (₹)491.83448.11419.85400.25352.89299.76262.36

Web traffic of Bioseed

The website of Bioseed (bioseed.com) receives about 1.4K visits a month.

  • Monthly visits
    1.4K

    ▲ 16.8% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Bioseed

DCMSHRIRAM: Q2 CONS NET PROFIT 1.05B RUPEES VS 1.6B (YOY)
Exchange Update • 2 days ago
DCMSHRIRAM: Q2 REVENUE 41.5B RUPEES VS 34.3B (YOY)
Exchange Update • 2 days ago
DCM Shriram: Company Plans To Spend Up To 600 Million Rupees On Installing Filter Presses At Kota Cement Plant.
Exchange Update • 2 days ago
DCM Shriram: Company Announces 4 Rupee Interim Dividend Per Share
Exchange Update • 2 days ago
DCM Shriram: Company Starts New 100 TPD Aluminum Chloride Plant and 133 TPD Calcium Chloride Production Line in Bharuch.
Exchange Update • 28 days ago
Aditya A. Shriram & Prashant J. Mahale re-elected as President & Vice President of AMAI
Business Standard • 1 month ago
Dcm Shriram Commissions Main Aluminium Extrusion Plant At Kota Unit
Reuters • 1 month ago
DCM Shriram Industries Ltd Says June-Quarter Net Profit 15.5 Million Rupees
Reuters • 2 months ago
DCMSHRIRAM: Strong Q1 growth in chemicals and advanced materials, with robust liquidity and ongoing CapEx
Quartr • 3 months ago
Buzzing Stocks: L&T, DCM Shriram rally up to 4% on strong Q1 earnings; RVNL gains 3% on ₹359 crore railway order
Moneycontrol • 3 months ago
Premium access

Complete news archive for Bioseed

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bioseed

Bioseed was founded in 1992.

Bioseed is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

Bioseed has 5,854 employees.

The primary company behind Bioseed, Dcm Shriram Limited, reported revenue of ₹14,249 Cr for FY 2026, up 13% year on year.

Bioseed was founded in 1992 in Hyderabad, India, focusing on the agricultural genetics sector. Improved seed varieties for various crops are developed through research, production, and field trials. High-quality seeds are delivered to farmers, with support provided to optimize their use. Agricultural productivity is enhanced via these genetic advancements, with operations centered in India.

Yes, Bioseed is publicly traded on NSE under the ticker symbol DCMSHRIRAM.

Bioseed operates through Dcm Shriram Limited.

The legal entities of Bioseed currently have 16 directors, including Krishan Kumar Sharma, Pranam Wahi, Ajit Shridhar Shriram and others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available